A groundbreaking study in Nature Cardiovascular Research uncovers promising drug targets for heart failure (HF) and its ...

Leinco Technologies, a leader in antibody and protein development, is thrilled to announce that it has been awarded a $1 M ...

The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...

By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...

Organoids were cultured from healthy donor iPSC sources and differentiated using the human iPSC-derived Cerebral Organoid ...

A new collection of articles offering expert insight and policy recommendations to tackle the national cardiovascular health ...

Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

The Royal Devon University Healthcare NHS Foundation Trust is leading ground-breaking clinical research that has the ...

Experiencing pain may increase the odds that cancer survivors will use cigarettes and cannabis, according to a recent study published by Wiley online in CANCER, a peer-reviewed journal of the American ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

We hope to be cured when we stay in hospital. But too often, we acquire new infections there. Such 'healthcare-associated infections' (HAI) are a growing problem worldwide, taking up an estimated 6% ...